drugset / Trial / NCT06238011

Dexmedetomidine vs Control on Attenuation Hemodynamic Response to Noxious Stimuli in CABG Surgical Patients

NCT06238011 ↗

Unknown 60 enrolled Sawanpracharak hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Aim to study efficacy of dexmedetomidine to attenuate hemodynamic response to intubation, skin incision, sternotomy and aortic cannulation

Timeline

Start
2024-02-28
Primary completion
2024-04-30
Completion
2024-05-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg —

Indications

No indication recorded.